Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study.

Kivipelto M, Rovio S, Ngandu T, Kåreholt I, Eskelinen M, Winblad B, Hachinski V, Cedazo-Minguez A, Soininen H, Tuomilehto J, Nissinen A.

J Cell Mol Med. 2008 Dec;12(6B):2762-71. doi: 10.1111/j.1582-4934.2008.00296.x. Epub 2008 Feb 8.

2.

Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study.

Laitinen MH, Ngandu T, Rovio S, Helkala EL, Uusitalo U, Viitanen M, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M.

Dement Geriatr Cogn Disord. 2006;22(1):99-107. Epub 2006 May 19.

PMID:
16710090
3.

Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia.

Luck T, Riedel-Heller SG, Luppa M, Wiese B, Köhler M, Jessen F, Bickel H, Weyerer S, Pentzek M, König HH, Prokein J, Ernst A, Wagner M, Mösch E, Werle J, Fuchs A, Brettschneider C, Scherer M, Maier W.

Psychol Med. 2014 Apr;44(6):1319-29. doi: 10.1017/S0033291713001918. Epub 2013 Jul 24.

PMID:
23883793
4.

How can elderly apolipoprotein E ε4 carriers remain free from dementia?

Ferrari C, Xu WL, Wang HX, Winblad B, Sorbi S, Qiu C, Fratiglioni L.

Neurobiol Aging. 2013 Jan;34(1):13-21. doi: 10.1016/j.neurobiolaging.2012.03.003. Epub 2012 Apr 11.

PMID:
22503000
5.

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702. Epub 2012 Oct 30.

PMID:
23146133
6.

Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study.

Rusanen M, Kivipelto M, Levälahti E, Laatikainen T, Tuomilehto J, Soininen H, Ngandu T.

J Alzheimers Dis. 2014;42(1):183-91. doi: 10.3233/JAD-132363.

PMID:
24825565
7.

Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA.

Neurology. 1996 Mar;46(3):673-7.

PMID:
8618665
8.

APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.

Huang W, Qiu C, von Strauss E, Winblad B, Fratiglioni L.

Arch Neurol. 2004 Dec;61(12):1930-4. Erratum in: Arch Neurol. 2005 Mar;62(3):453.

PMID:
15596614
9.

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO.

BMC Neurol. 2008 Apr 16;8:9. doi: 10.1186/1471-2377-8-9.

10.

Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Langbaum JB, Chen K, Caselli RJ, Lee W, Reschke C, Bandy D, Alexander GE, Burns CM, Kaszniak AW, Reeder SA, Corneveaux JJ, Allen AN, Pruzin J, Huentelman MJ, Fleisher AS, Reiman EM.

Arch Neurol. 2010 Apr;67(4):462-8. doi: 10.1001/archneurol.2010.30.

11.

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.

Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ.

Arch Neurol. 2008 Jan;65(1):89-93. doi: 10.1001/archneurol.2007.29.

PMID:
18195144
12.

Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish brain power initiative.

Wang HX, Gustafson DR, Kivipelto M, Pedersen NL, Skoog I, Windblad B, Fratiglioni L.

Neurobiol Aging. 2012 May;33(5):1007.e1-7. doi: 10.1016/j.neurobiolaging.2011.10.003. Epub 2011 Nov 5.

PMID:
22056199
13.

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.

Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

Neurobiol Aging. 2014 Sep;35(9):2096-106. doi: 10.1016/j.neurobiolaging.2014.03.006. Epub 2014 Mar 11.

14.

Interaction of Apolipoprotein E Genotypes, Lifestyle Factors and Future Risk of Dementia-Related Mortality: The Cohort of Norway (CONOR).

Strand BH, Rosness TA, Engedal K, Magnus P, Bergem AL, Schirmer H, Bjertness E, Knudsen GP.

Dement Geriatr Cogn Disord. 2015;40(3-4):137-47. doi: 10.1159/000431218. Epub 2015 Jun 12.

PMID:
26088392
15.

Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.

Irie F, Masaki KH, Petrovitch H, Abbott RD, Ross GW, Taaffe DR, Launer LJ, White LR.

Arch Gen Psychiatry. 2008 Aug;65(8):906-12. doi: 10.1001/archpsyc.65.8.906.

16.

Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use.

Jacobs EG, Kroenke C, Lin J, Epel ES, Kenna HA, Blackburn EH, Rasgon NL.

PLoS One. 2013;8(2):e54713. doi: 10.1371/journal.pone.0054713. Epub 2013 Feb 13.

17.

Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.

Corrada MM, Paganini-Hill A, Berlau DJ, Kawas CH.

Alzheimers Dement. 2013 Jan;9(1):12-8. doi: 10.1016/j.jalz.2011.12.004. Epub 2012 Nov 2.

18.

Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.

Olarte L, Schupf N, Lee JH, Tang MX, Santana V, Williamson J, Maramreddy P, Tycko B, Mayeux R.

Arch Neurol. 2006 Nov;63(11):1586-90.

PMID:
17101827
19.

Association of parental dementia with cognitive and brain MRI measures in middle-aged adults.

Debette S, Wolf PA, Beiser A, Au R, Himali JJ, Pikula A, Auerbach S, Decarli C, Seshadri S.

Neurology. 2009 Dec 15;73(24):2071-8. doi: 10.1212/WNL.0b013e3181c67833. Epub 2009 Dec 9.

20.

Work-related physical activity and the risk of dementia and Alzheimer's disease.

Rovio S, Kåreholt I, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M.

Int J Geriatr Psychiatry. 2007 Sep;22(9):874-82.

PMID:
17721898

Supplemental Content

Support Center